Search Results 1271-1280 of 18283 for anaphylaxis

1. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   Intolerance to a biologic may include, but not be limited to infusion-related reaction, rash, serum sickness, anaphylaxis, elevated liver enzymes ...

2. Transforaminal Lumbar Interbody Fusion (TLIF) - Mayo Clinic

   15 History of any allergy resulting in anaphylaxis. - E.16 Is a prisoner. - E.17 Is mentally incompetent. If questionable, obtain psychiatric consult. - E ...

3. Piercings: How to prevent complications - Mayo Clinic

   Know the risks · Allergic reactions. Some jewelry used with a piercing can cause allergic reactions. · Skin infections. An infection can cause redness, pain and ...

4. A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301) - Mayo Clinic

   Prior anaphylactic or other severe infusion reaction associated with human antibody administration that cannot be managed with standard supportive measures.

5. Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery - Mayo Clinic

   Known hypersensitivity or previous anaphylaxis to SnPP or any tin-based product. Serum ferritin > 500 ng/mL or those who have received IV iron within 28 ...

6. Publications - Pierre Noel, M.D. - Mayo Clinic

   Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood. 2007 Oct 1; 110(7):2331 ...

7. Mayo Clinic Minute: When asthma attacks

   Asthma is a lung condition that causes swelling of the airways. It can make breathing difficult and trigger coughing, wheezing and shortness of breath.

8. A Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma - Mayo Clinic

   hypersensitivity, allergy, or anaphylactic ... discontinuation. - Patients with prior significant hypersensitivity to rituximab requiring discontinuation, prior ...

9. BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma - Mayo Clinic

   Hypersensitivity to the active substance or to any of the excipients for study drug BT062, or history of severe allergic or anaphylactic reaction to therapeutic ...

10. https://www.mayoclinic.org/chinese_organization_concepts.xml